In: Industry trends
We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug…Read More
Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery typically uses…Read More
Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope with tight margins…Read More
If you validated the drug target to cure a disease, but can’t hit it efficiently with high-throughput screening (HTS), fragment-based drug discovery could be…Read More
04 Feb, 2014Sequencing and Drug Discovery: How does Illumina’s new $1000 human genome affect drug discovery?
Illumina recently announced the $1000 solution for the sequencing of the human genome in the form of its new instrument, the HiSeqX. This…Read More